Home
AtomVie Global Radiopharma

AtomVie Global Radiopharma Market Share Analysis for August 2026

Explore careers at AtomVie and help advance next-generation radioligand therapies through GMP radiopharmaceutical manufacturing and supply.

Industry: N/A

Domainatomvie.com

Year Founded2021

Employees51 - 200

Annual Revenue--

AtomVie Global Radiopharma

AtomVie Global Radiopharma (including company regionals)

atomvie.com

See more website traffic and engagement information

Total visits to AtomVie Global Radiopharma's top domains

Understand AtomVie Global Radiopharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

atomvie.com1.1K

See more with Sales Intelligence

Avg. visit duration in AtomVie Global Radiopharma's top domains

Analyze AtomVie Global Radiopharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

atomvie.com--

See more with Sales Intelligence

Avg. pageviews on AtomVie Global Radiopharma's top domains

See how AtomVie Global Radiopharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

atomvie.com1.11

See more with Sales Intelligence

AtomVie Global Radiopharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by AtomVie Global Radiopharma

These are the website technologies, by industry, used by AtomVie Global Radiopharma top domains

Widget (5)

Twemoji

Email Services (2)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

Content Management System (1)

WordPress

More Technologies

6

See all

News & Signals from AtomVie Global Radiopharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAtomVie Global Radiopharma Inc. expanded facilities to Canada, Northern America, Americas on Sep 8th '26.AtomVie opens $160 million radiopharmaceutical facility in Canada.

NewsAtomVie Global Radiopharma Inc. invested into assets: radiopharmaceutical manufacturing facility in the amount of $160M in Hamilton, Ontario, Canada, Northern America, Americas on Sep 5th '26.AtomVie opens $160m radiopharmaceutical manufacturing facility in Ontario.

NewsRadiopharm Theranostics Ltd. partnered with AtomVie Global Radiopharma Inc. on Oct 1st '24.In October 2024, Radiopharm Theranostics and AtomVie entered a partnership for the development and manufacturing of 177Lu-BetaBart radioantibody to treat multiple solid tumours.